According to the MHRA-approved product information, nausea is very common, occurring in more than 1 in 10 patients
Serious Warning Signs If you experience any of the following, you should stop taking naproxen and contact a healthcare provider immediately: Severe abdominal pain that does not go away Dark, tarry, or bloody stools (a sign of potential GI bleeding) Persistent vomiting or the inability to keep fluids down A significant decrease in urine output or dark-colored urine Note: If you have a history of stomach ulcers, kidney disease, or are taking blood thinners like warfarin (Jantoven), you must consult your doctor before taking naproxen with any GLP-1 medication
#Pharmacovigilance #DrugSafety #ClinicalResearch #ICSR #MedicalReview #SafetyPhysician #SafetyPhysicians #MBBS #BachelorsOfMedicine #BachelorsOfSurgery #MasterOfMedicine #MasterOfSurgery #CausalityAssessment #CaseProcessing #AdverseEvents #SignalDetection #RiskBenefitAnalysis #PV #PharmaIndustry #HealthcareResearch #LifeSciences #RegulatoryAffairs #FDACompliance #ICHGuidelines #ClinicalTrials #DrugMonitoring #MedicalWriting #PharmacovigilanceTraining #Cliniminds #ClinicalSafety Medical Review of ICSRs Cliniminds Drug Safety & Medical Review for Physicians To view or add a comment, sign in Medical Review of ICSRs Cliniminds Drug Safety & Medical Review for Physicians Medical review of Individual Case Safety Reports (ICSRs) by physicians is a critical pharmacovigilance process, ensuring accuracy, causality assessment, and regulatory compliance
Tirzepatide works on two different hormone systems instead of just one
Gastrointestinal issues were more common side effects in the Wegovy group, and included nausea, diarrhea, constipation, and vomiting
